These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31632735)

  • 1. Treatment of at-level spinal cord injury pain with botulinum toxin A.
    Chun A; Levy I; Yang A; Delgado A; Tsai CY; Leung E; Taylor K; Kolakowsky-Hayner S; Huang V; Escalon M; Bryce TN
    Spinal Cord Ser Cases; 2019; 5():77. PubMed ID: 31632735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of subcutaneous injection of botulinum toxin A on spinal cord injury-associated neuropathic pain.
    Han ZA; Song DH; Chung ME
    Spinal Cord; 2014 Jun; 52 Suppl 1():S5-6. PubMed ID: 24902645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin type A for neuropathic pain in patients with spinal cord injury.
    Han ZA; Song DH; Oh HM; Chung ME
    Ann Neurol; 2016 Apr; 79(4):569-78. PubMed ID: 26814620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
    Utomo E; Groen J; Blok BF
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD004927. PubMed ID: 24859260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of botulinum toxin A for treating neuropathic pain in patients with spinal cord injury.
    Li G; Lv CA; Tian L; Jin LJ; Sun P; Zhao W
    Medicine (Baltimore); 2017 May; 96(20):e6919. PubMed ID: 28514309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type A for facial wrinkles.
    Camargo CP; Xia J; Costa CS; Gemperli R; Tatini MD; Bulsara MK; Riera R
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD011301. PubMed ID: 34224576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.
    Cruz F; Herschorn S; Aliotta P; Brin M; Thompson C; Lam W; Daniell G; Heesakkers J; Haag-Molkenteller C
    Eur Urol; 2011 Oct; 60(4):742-50. PubMed ID: 21798658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrarectal injections of botulinum toxin versus placebo for the treatment of urge faecal incontinence in adults (FI-Toxin): a double-blind, multicentre, randomised, controlled phase 3 study.
    Leroi AM; Queralto M; Zerbib F; Siproudhis L; Vitton V; Amarenco G; Etienney I; Mion F; Bridoux V; Philip J; Brochard C; Damon H; Lacroix E; Gillibert A; Gourcerol G
    Lancet Gastroenterol Hepatol; 2024 Feb; 9(2):147-158. PubMed ID: 38128556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detrusor botulinum toxin A injection significantly decreased urinary tract infection in patients with traumatic spinal cord injury.
    Jia C; Liao LM; Chen G; Sui Y
    Spinal Cord; 2013 Jun; 51(6):487-90. PubMed ID: 23357928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acupoint injection of onabotulinumtoxin A for migraines.
    Hou M; Xie JF; Kong XP; Zhang Y; Shao YF; Wang C; Ren WT; Cui GF; Xin L; Hou YP
    Toxins (Basel); 2015 Oct; 7(11):4442-54. PubMed ID: 26529014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial.
    Attal N; de Andrade DC; Adam F; Ranoux D; Teixeira MJ; Galhardoni R; Raicher I; Üçeyler N; Sommer C; Bouhassira D
    Lancet Neurol; 2016 May; 15(6):555-65. PubMed ID: 26947719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Stark SR; Lucas SM; Christie SN; Degryse RE; Turkel CC;
    Mayo Clin Proc; 2005 Sep; 80(9):1126-37. PubMed ID: 16178492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship Between Botulinum Toxin, Spasticity, and Pain: a Survey of Patient Perception.
    Shaikh A; Phadke CP; Ismail F; Boulias C
    Can J Neurol Sci; 2016 Mar; 43(2):311-5. PubMed ID: 26691344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity.
    Rosales RL; Chua-Yap AS
    J Neural Transm (Vienna); 2008; 115(4):617-23. PubMed ID: 18322637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial.
    Kaji R; Osako Y; Suyama K; Maeda T; Uechi Y; Iwasaki M;
    J Neurol; 2010 Aug; 257(8):1330-7. PubMed ID: 20358216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache.
    Mathew NT; Kailasam J; Meadors L
    Headache; 2008 Feb; 48(2):194-200. PubMed ID: 17868356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can Botulinum Toxin Type A effectively treat neuropathic pain in spinal cord injury?: A protocol of systematic review and meta-analysis.
    Wang ZM; Wang ZY; Wei CJ; Jiang YJ
    Medicine (Baltimore); 2020 Jun; 99(25):e20702. PubMed ID: 32569202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine.
    Saper JR; Mathew NT; Loder EW; DeGryse R; VanDenburgh AM;
    Pain Med; 2007 Sep; 8(6):478-85. PubMed ID: 17716321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.